Commentary
Recently published articles about Commentary
Commentary
Prescribing GLP-1 Receptor Agonists for Persons With Mental Disorders: Evidence-Based and Aspirational Targets
June 1, 2026
Evidence-based prescription of GLP-1 RAs in persons with serious mental illness and/or substance use disorders holds promise to improve their health and wellbeing and possibly reduce excess mortality.
Commentary
Biography Inscribed in Biology: Diagnostic Criteria for Psychosomatic Research and the Embodiment of Lived Experience
March 25, 2026
The DCPR framework, with its emphasis on allostatic overload, provides evidence that biography becomes biology and that lived experience is inscribed into our physiological systems.
Commentary
Mind-Body Integration and East-West Fusion for Modern Medicine: Insights from the Diagnostic Criteria for Psychosomatic Research
March 25, 2026
Clinimetrics not only lays the methodological foundation for the promotion of the DCPR but also shows potential in interdisciplinary applications.
Recent JCP Articles on Commentary
Commentary
Prioritizing Mental Health to Optimize Perinatal, Fetal, and Neonatal Outcomes
September 24, 2025
Following an FDA panel discussion on use of SSRIs in pregnancy, the authors highlight the need for balanced conversations and shared decision-making accounting for the risks of untreated disease...
Recent PCC Articles on Commentary
Featured Commentary Research
Clinical and Practical Psychopharmacology
Gestational Exposure to Sterol Biosynthesis Disrupting Drugs and Risk of Autism Spectrum Disorder
June 15, 2026
Dr Andrade discusses a recent study of sterol biosynthesis disrupting drugs and argues that inadequate research methods disallow clinical application of the results.
Commentary
Precision Medicine for Suicide Prevention: It’s Time to Take the Next Step
December 22, 2025
The authors recommend moving toward a precision medicine approach to suicide prevention that considers the person, their circumstances and biology, treatment delivery context, and conditions that contribute to the...
Commentary
Beyond the Boxed Warning: A Call for Regulation of Psychiatry’s Most Teratogenic Drug
October 6, 2025
The authors assert that while valproate remains invaluable for certain severe conditions, the high risk of teratogenicity means stringent safeguards are needed to regulate its use by individuals capable...
